PLD4 Gene

PLD4 (Phospholipase D4)

<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td><strong>PLD4</strong></td></tr>
<tr><th>Full Name</th><td>Phospholipase D4</td></tr>
<tr><th>Chromosomal Location</th><td>22q12.1</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/122809" target="_blank">122809</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/614786" target="_blank">614786</a></td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000138184</td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprotkb/Q96BZ4" target="_blank">Q96BZ4</a></td></tr>
<tr><th>Associated Diseases</th><td>Autoimmune disorders, Cerebellar ataxia, Inflammatory bowel disease</td></tr>
</table>
</div>

Overview

PLD4 (Phospholipase D4) encodes a member of the phospholipase D family that possesses both phospholipase D enzymatic activity and 5'→3' exonuclease capability. Unlike classical phospholipases involved in lipid signaling, PLD4 performs unique functions in innate immunity through its ability to degrade nucleic acids and regulate Toll-like receptor (TLR) signaling pathways[@gondard2017]. The gene is expressed predominantly in immune cells and is increasingly recognized for its role in preventing aberrant inflammatory responses.

Molecular Function

Phospholipase D Activity

PLD4 (Phospholipase D4)

<div class="infobox infobox-gene">
<table>
<tr><th>Gene Symbol</th><td><strong>PLD4</strong></td></tr>
<tr><th>Full Name</th><td>Phospholipase D4</td></tr>
<tr><th>Chromosomal Location</th><td>22q12.1</td></tr>
<tr><th>NCBI Gene ID</th><td><a href="https://www.ncbi.nlm.nih.gov/gene/122809" target="_blank">122809</a></td></tr>
<tr><th>OMIM</th><td><a href="https://www.omim.org/entry/614786" target="_blank">614786</a></td></tr>
<tr><th>Ensembl ID</th><td>ENSG00000138184</td></tr>
<tr><th>UniProt ID</th><td><a href="https://www.uniprot.org/uniprotkb/Q96BZ4" target="_blank">Q96BZ4</a></td></tr>
<tr><th>Associated Diseases</th><td>Autoimmune disorders, Cerebellar ataxia, Inflammatory bowel disease</td></tr>
</table>
</div>

Overview

PLD4 (Phospholipase D4) encodes a member of the phospholipase D family that possesses both phospholipase D enzymatic activity and 5'→3' exonuclease capability. Unlike classical phospholipases involved in lipid signaling, PLD4 performs unique functions in innate immunity through its ability to degrade nucleic acids and regulate Toll-like receptor (TLR) signaling pathways[@gondard2017]. The gene is expressed predominantly in immune cells and is increasingly recognized for its role in preventing aberrant inflammatory responses.

Molecular Function

Phospholipase D Activity

PLD4 functions as a phospholipase D that catalyzes the hydrolysis of phospholipids to generate phosphatidic acid. A distinctive feature of PLD4 is its specificity for synthesizing (S,S)-bis(monoacylglycero)phosphate (BMP), also known as lysobisphosphatidic acid (LBPA), a critical phospholipid in lysosomal lipid degradation[@acland2018]. BMP is essential for proper lysosomal function and autophagy, and PLD4 represents the primary enzymatic source of this lipid species in mammals.

Exonuclease Activity

PLD4 possesses 5'→3' exonuclease activity that degrades single-stranded DNA (ssDNA) and RNA. This activity is crucial for its role in:

• Mitochondrial DNA clearance: PLD4 degrades mitochondrial DNA (mtDNA) released into the cytosol, preventing excessive TLR9 activation[@moriya2019]
• Prevention of autoinflammation: By clearing nucleic acid debris, PLD4 maintains immune tolerance and prevents inappropriate activation of innate immune sensors
• Generation of TLR7 ligands: Paradoxically, PLD4 can also cleave viral RNA to generate ligands for TLR7, enabling antiviral immunity[@gondard2017]

Role in Neurodegenerative Diseases

While PLD4 is primarily studied in the context of innate immunity and autoinflammatory disorders, emerging evidence suggests connections to neurodegenerative processes:

Neuroinflammation Regulation

PLD4-regulated TLR signaling pathways are directly relevant to neuroinflammation in Alzheimer's disease (AD) and Parkinson's disease (PD):

• TLR9 and TLR7 activation in microglia triggers pro-inflammatory cytokine production
• PLD4 deficiency leads to heightened neuroinflammation in mouse models
• Chronic neuroinflammation is a hallmark of neurodegenerative diseases

Autoimmune- Neurological Comorbidity

Polymorphisms in PLD4 have been associated with autoimmune conditions that show comorbidity with neurodegenerative diseases:

• Rheumatoid arthritis[@kotake2019]
• Systemic lupus erythematosus
• Inflammatory bowel disease

Brain Expression

PLD4 expression in the brain is primarily localized to:

• Microglia: The resident immune cells of the central nervous system
• Astrocytes: To a lesser extent
• Oligodendrocytes: In white matter regions

Protein Interactions

PLD4 interacts with several proteins relevant to its enzymatic functions:

• TLR9: Negatively regulates TLR9-mediated signaling
• TLR7: Can generate ligands for TLR7 activation
• ATG proteins: Involved in autophagy and lysosomal function
• Lysosomal enzymes: Part of the lysosomal degradation machinery

Therapeutic Implications

Modulating PLD4 activity represents a potential therapeutic strategy:

• PLD4 inhibition: May enhance antitumor immunity by releasing TLR9 ligands
• PLD4 augmentation: Could potentially reduce neuroinflammation in AD and PD
• Targeted drug development: Small molecule modulators of PLD4 are under investigation[@suzuki2020]

Animal Models

PLD4-deficient mice develop spontaneous autoinflammatory disease characterized by:

• Splenomegaly
• Elevated pro-inflammatory cytokines
• Autoantibody production
• Inflammatory lesions in multiple organs[@han2018]

Mutations and Genetic Variants

Pathogenic variants in PLD4 have been associated with:

• Cerebellar ataxia: Biallelic loss-of-function mutations cause cerebellar degeneration[@zhao2019]
• Autoimmune susceptibility: Common polymorphisms increase risk for autoimmune diseases
• Inflammatory phenotypes: Hypomorphic variants contribute to chronic inflammation

Summary

PLD4 represents a unique intersection of phospholipid metabolism, nucleic acid degradation, and innate immunity. While not traditionally considered a neurodegeneration gene, its role in regulating neuroinflammatory pathways through TLR signaling places it in the broader context of neurodegenerative disease mechanisms. Further research into PLD4 function may reveal therapeutic targets for modulating neuroinflammation in AD, PD, and related disorders.

See Also

• [TLR9 Signaling](/mechanisms/tlr9-signaling)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Microglial Activation](/cell-types/microglia)
• [Alzheimer's Disease Mechanisms](/mechanisms/alzheimers-disease Overview)
• [Parkinson's Disease Mechanisms](/mechanisms/parkinsons-disease-overview)

References